Skip Nav Destination
Issues
1 January 2006
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Editorial
Hypothesis/Commentary
Commentary
Research Articles
The AIB1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Amanda B. Spurdle; Antonis C. Antoniou; Livia Kelemen; Helene Holland; Susan Peock; Margaret R. Cook; Paula L. Smith; Mark H. Greene; Jacques Simard; Marie Plourde; Melissa C. Southey; Andrew K. Godwin; Jeanne Beck; Alexander Miron; Mary B. Daly; Regina M. Santella; John L. Hopper; Esther M. John; Irene L. Andrulis; Francine Durocher; Jeffery P. Struewing; Douglas F. Easton; Georgia Chenevix-Trench; Australian Breast Cancer Family Study; Australian Jewish Breast Cancer Study; Breast Cancer Family Registry; Interdisciplinary Health Research International Team on Breast Cancer Susceptibility; The Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer; Epidemiological Study of Familial Breast Cancer Study Collaborators
Short Communications
Null Results in Brief
No Association Between the MDM2 −309 T/G Promoter Polymorphism and Breast Cancer in African-Americans or Whites
Robert C. Millikan; Kimberley Heard; Scott Winkel; Edgar J. Hill; Kristin Heard; Beri Massa; Lydia Mayes; Patricia Williams; Rachel Holston; Kathleen Conway; Sharon Edmiston; Allan René de Cotret
No Evidence For Large-scale Germline Genomic Aberrations in Hereditary Bladder Cancer Patients with High-Resolution Array-Based Comparative Genomic Hybridization
Lambertus A. Kiemeney; Roland P. Kuiper; Rolph Pfundt; Simon van Reijmersdal; Mark P. Schoenberg; Katja K. Aben; Martinus F. Niermeijer; J. Alfred Witjes; Eric F.P.M. Schoenmakers
Note from the Editors
Letters to the Editor
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.